A detailed history of Envestnet Portfolio Solutions, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 1,001 shares of UTHR stock, worth $380,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,001
Previous 960 4.27%
Holding current value
$380,069
Previous $305,000 17.38%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$311.04 - $363.55 $12,752 - $14,905
41 Added 4.27%
1,001 $358,000
Q2 2024

Jul 16, 2024

BUY
$228.26 - $319.04 $219,129 - $306,278
960 New
960 $305,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Envestnet Portfolio Solutions, Inc. Portfolio

Follow Envestnet Portfolio Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Portfolio Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Portfolio Solutions, Inc. with notifications on news.